KauffmanCA. Histoplasmosis: a clinical and laboratory update. Clin Microbiol Rev. 2007;20(1):115-132.
2.
GoodwinRADes PrezRM. State of the art: histoplasmosis. Am Rev Respir Dis. 1978;117(5):929-956.
3.
Lázár-MolnárEGárserAFreemanGJ, et al.The PD-1/PD-L costimulatory pathway critically affects host resistance to the pathogenic fungus Histoplasma capsulatum. Proc Natl Acad Sci USA. 2008;105(7):2658-2663.
4.
Burillo-MartinezSMorales-RayaCPrieto-BarriosM, et al.Pembrolizumab-induced extensive panniculitis and nevus regression: two novel cutaneous manifestations of the post-immunotherapy granulomatous reactions spectrum. JAMA Dermatol. 2017;153(7):721-722.
